alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document

Exhibit 10.6
CERTAIN INFORMATION IDENTIFIED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.





April 23, 2021
Novavax, Inc.
21 Firstfield Road
Gaithersburg, MD 20878
Attention:    [***]
Subject:    Modification No. 07 to Project Agreement No. 01; MCDC2011-001
Reference:    MCDC Base Agreement No. 2020-530
Dear [***]:
In accordance with the terms and conditions of the referenced MCDC Base Agreement, Modification No. 07 hereby amends the Project Agreement No. 01 as follows:
DESCRIPTION OF MODIFICATION
1)    The Incremental Funding clause of the Project Agreement is hereby amended to read as indicated in bold below:
5. INCREMENTAL FUNDING
The total amount of funding currently available for payment and allotted to this Project Agreement is $1,747,689,328 (this is an increase of $147,349,805). The amount specified, or as such amount may be increased from time to time, shall apply irrespective of any other provisions of this Project Agreement and any work performed in excess thereof shall be at the Project Agreement Holder’s risk. This amount covers all allowable direct and indirect costs as well as the associated fixed fee. If at any time the Project Agreement Holder has reason to believe that the Total Estimated Cost which will accrue in the performance of this Project Agreement in the next succeeding [***], when added to all other payments previously accrued, will exceed [***] of the then current total authorized funding, the Project Agreement Holder shall notify the MCDC CMF to that effect, advising the estimate of additional funds required for the period specified. The Project Agreement Holder is not obligated to continue performance under this Project Agreement (including actions under the Termination clause of the MCDC Base Agreement) or otherwise incur costs in excess of the amount allotted to the Project Agreement by the MCDC CMF.
Except as provided herein, all Terms and Conditions of the referenced MCDC Base Agreement, Project Agreement and preceding modifications remain unchanged and in full force and effect.
This modification is issued unilaterally. The Project Agreement Holder is not required to sign to finalize this action.
Advanced Technology International
By: /s/ [***]    
99315055_4






Name: [***]    
Title: Advanced Technology International Director, Contracts & Procurement
Date: April 23, 2021
    -2-
99315055_4
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Harry K. Dupree Stuttgart National Aquaculture Research Cntr: Stuttgart, AR
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Southeast Area Stuttgart, Arkansas Harry K. Dupree Stuttgart National Aquaculture Research Cntr People & Locations







Jeff  Bouscher
                        Harry K. Dupree Stuttgart National Aquaculture Research Cntr

                        




                        
                        Maintenance Worker
                        Phone: (870) 672-8256
                        
                        
                        Fax: (870) 673-7710(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
#### McManus *v.*Cash Grocery Company.

June 30, 1915.

Lumpkin, J.

1. Where suit was brought upon a promissory note against one defendant as maker thereof, and the other as indorser, and on the trial the defendants admitted a prima facie case, assumed the burden of proof, and proceeded to introduce evidence, this was sufficient to show that the note had been made by the alleged principal defendant and had been indorsed to the plaintiff by the other defendant.

2. Where a negotiable promissory note is sued on by an indorsee thereof, in the absence of any evidence to the contrary the presumption is that it was indorsed for vahie and before due. *Bank of Stewart County*v. *Adams,*96 *Ga.*529 (23 S. E. 496).

3. The mere fact that an indorsee of a negotiable promissory note, taken by him for value, has notice that the note was given to the payee for commissions as a real-estate agent, is not sufficient to put him on notice or inquiry as to whether the consideration failed. *Howard*v. Simpkins, 70 *Ga.*322.

4. Although a person may not have registered and paid the tax required of a real-estate agent, this will not prevent a recovery upon a promissory note given to him for commissions in connection with selling property. *Toole*v. *Wiregrass Development Company,*142 *Ga.*57 (82 S. E. 514), *Judgment affirmed.*

*All the Justices concur.*

*624Complaint. Before Judge Conyers. Jeff Davis superior court. February 17, 1914.

*'8. J). Dell,*for plaintiff in error.

*J. G. Bennett*and *J. M. Swain Jr.,*contra.
#### The People of the State of New York, Respondent, v Miguel Tavare, Appellant.

—Appeal by the defendant from a judgment of the Supreme Court, Queens County (Rotker, J.), rendered November 3, 1983, convicting him of criminal sale of a controlled substance in the third degree, after a nonjury trial, and imposing sentence.

Judgment affirmed.

The defendant’s guilt was proven beyond a reasonable doubt *(see, People v Contes,*60 NY2d 620, 621). The defendant’s contention that his first felony conviction cannot serve as the basis for sentencing him as a second felony offender because he was not advised, prior to the plea resulting in the original felony conviction, that he would thereafter be subject to. enhanced punishment, is without merit *(see, People v Towles,*110 AD2d 729). Gibbons, J. P., Brown, Lawrence and Kooper, JJ., concur.
<PAGE>
                                                                      Exhibit 32


                                  CERTIFICATION
      Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906
                        of the Sarbanes-Oxley Act of 2002





         Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of CVF
Technologies Corporation (the "Company"), does hereby certify, to such officer's
knowledge, that:

         The Quarterly Report on Form 10-QSB for the quarter ended September 30,
2003 (the "Form 10-Q") of the Company fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the
information contained in the Form 10-QSB fairly presents, in all material
respects, the financial condition and results of operations of the Company.





Dated:   November 14, 2003                   /s/ Jeffrey I. Dreben
                                             ---------------------
                                             Jeffrey I. Dreben,
                                             Chief Executive Officer




Dated:   November 14, 2003                   /s/ Robert L. Miller
                                             --------------------
                                             Robert L. Miller,
                                             Chief Financial Officer



         This certification is being furnished solely to accompany the Form 10-Q
pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company unless such
incorporation is expressly referenced therein.
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

EDWARD ARTHUR GEIER, JR.,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 639 MAL 2021

Petition for Allowance of Appeal 

from the Order of the Superior Court

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

EDWARD ARTHUR GEIER, JR.,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 640 MAL 2021

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 31st day of May, 2022, the Petition for Allowance of Appeal is 

DENIED.
EXHIBIT 11Thefollowing table sets forth the computation of basic and diluted earnings per share:           (Expressed in U.S. Currency)   Three months ended March 31,   2007  2006 Numerator:        Net (loss) $(437,908) $(480,834)Dividends on Series A preferred stock  (358)  (936)                Numerator for basic and diluted loss pershare loss available to common shareholders $(438,266) $(481,770)                Denominator:        Denominator for basic loss per share-weighted average shares outstanding  12,637,735   13,722,074 Effect of dilutive securities  —   — Warrants  —   —                 Dilutive potential common shares denominatorfor diluted earnings (loss) per share adjustedweighter-average shares and assumed conversion  12,637,735   13,722,074                 Basic (loss) per share $(0.03) $(0.04)                Diluted (loss) per share $(0.03) $(0.04)
Case 1:03-cv-07749 Document 56-3 Filed 02/10/09 Page 1 of 6
Case 1:03-cv-07749 Document 56-3 Filed 02/10/09 Page 2 of 6
Case 1:03-cv-07749 Document 56-3 Filed 02/10/09 Page 3 of 6
Case 1:03-cv-07749 Document 56-3 Filed 02/10/09 Page 4 of 6
Case 1:03-cv-07749 Document 56-3 Filed 02/10/09 Page 5 of 6
Case 1:03-cv-07749 Document 56-3 Filed 02/10/09 Page 6 of 6
<TABLE> <S> <C>

<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   DEC-31-1997
<CASH>                                         1,162,793
<SECURITIES>                                   66,818
<RECEIVABLES>                                  67,558,269
<ALLOWANCES>                                   4,809,400
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         3,869,935
<DEPRECIATION>                                 1,866,148
<TOTAL-ASSETS>                                 60,965,672
<CURRENT-LIABILITIES>                          0
<BONDS>                                        52,086,424
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       37,956
<OTHER-SE>                                     5,928,810
<TOTAL-LIABILITY-AND-EQUITY>                   60,965,672
<SALES>                                        0
<TOTAL-REVENUES>                               22,583,875
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               13,210,791
<LOSS-PROVISION>                               6,579,932
<INTEREST-EXPENSE>                             5,023,179
<INCOME-PRETAX>                                (2,230,027)
<INCOME-TAX>                                   (723,694)
<INCOME-CONTINUING>                            (1,506,333)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,506,333)
<EPS-PRIMARY>                                  (0.39)
<EPS-DILUTED>                                  (0.39)
        


</TABLE>
<PAGE>
Exhibit 99.2

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Land O'Lakes, Inc. (the "Company") on
Form 10-Q for the period ending March 31, 2003 as filed with the Securities and
Exchange Commission on May 14, 2003 (the "Report"), I, Daniel Knutson, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350,
as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


                                        By  /s/ Daniel Knutson
                                        ----------------------------------
                                        Daniel Knutson
                                        Senior Vice President
                                        and Chief Financial Officer
[Federal Register Volume 86, Number 150 (Monday, August 9, 2021)]
[Notices]
[Page 43557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16901]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR19-319: NIDDK Central 
Repositories Non-Renewable Sample Access (X01) Review.
    Date: September 13, 2021.
    Time: 2:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8894, <a href="/cdn-cgi/l/email-protection#187a7d7f6d75765876717c7c7336767170367f776e"><span class="__cf_email__" data-cfemail="0567606270686b456b6c61616e2b6b6c6d2b626a73">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: August 4, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-16901 Filed 8-6-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Case: 1:01-cv-03228 Document #: 52 Filed: 03/28/02 Page 1 of 2 PageID #:252
Case: 1:01-cv-03228 Document #: 52 Filed: 03/28/02 Page 2 of 2 PageID #:253
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Neighborhood Reinvestment Corporation

# TIME AND DATE: 

3:00 p.m., Wednesday, August 11, 2021.

# PLACE: 

Via Conference Call.

# STATUS: 

Parts of this meeting will be open to the public. The rest of the meeting will be closed to the public.

# MATTERS TO BE CONSIDERED: 

Audit Committee Meeting.

The General Counsel of the Corporation has certified that in his opinion, one or more of the exemptions set forth in the Government in the Sunshine Act, 5 U.S.C. 552b (c)(2) and (4) permit closure of the following portion(s) of this meeting:

    - Executive Session

## Agenda

I. Call to Order

II. Executive Session with Chief Audit Executive

III. Action Item Request to Cancel Internal Audit Project: Tipalti-Third Party Vendor Contract

IV. Discussion Item Tracking Open Recommendations

a. Dependent on Other IT Projects

b. Monitoring Identity Access Management (IAM) Development

i. ITS Audit and Security Roadmap

V. Discussion Item Internal Audit Status Reports

a. Internal Audit Reports Awaiting Managements Response

 HPN Launchpad

                     Application and Systems Change Management                          ( print page 41877)    

 Promotions and Compensation

 Project Reinvest Wind-Down

 Grant Appropriations Disbursement

b. Internal Audit Performance Scorecard

c. FY21 Plan Projects' Activity Summary as of July 13, 2021

d. Implementation of Internal Audit Recommendations

VI. Adjournment

# CONTACT PERSON FOR MORE INFORMATION:

                        Lakeyia Thompson, Special Assistant, (202) 524-9940;                         *Lthompson@nw.org*.                    

Lakeyia Thompson,

Special Assistant.

[FR Doc. 2021-16645 Filed 7-30-21; 4:15 pm]

BILLING CODE 7570-02-P
`[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[S. 1336 Introduced in Senate (IS)]







105th CONGRESS
  1st Session
                                S. 1336

                  For the relief of Roy Desmond Moser.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            October 29, 1997

  Mr. Graham introduced the following bill; which was read twice and 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL


 
                  For the relief of Roy Desmond Moser.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MODIFICATION OF EFFECTIVE DATE OF NATURALIZATION OF ROY 
              DESMOND MOSER.

    Notwithstanding title III of the Immigration and Nationality Act, 
any predecessor provisions to such title, or any other provision of law 
relating to naturalization, for purposes of determining the eligibility 
of Roy Desmond Moser for relief under the Agreement Between the 
Government of the United States and the Government of the Federal 
Republic of Germany Concerning Final Benefits to Certain United States 
Nationals Who Were Victims of National Socialist Measures of 
Persecution, signed at Bonn on September 19, 1995, Roy Desmond Moser is 
deemed to be a naturalized citizen of the United States as of August 8, 
1942.`
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Insect Control and Cotton Disease Research: College Station, TX
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area College Station, Texas Southern Plains Agricultural Research Center Insect Control and Cotton Disease Research People & Locations







Robin F Mann
                        Insect Control and Cotton Disease Research

                        




                        
                        Office Automation Assistant
                        Phone: (979) 260-9351
                        
                        
                        Fax: (979) 260-9387(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov